Jamie L. McConaha, PharmD, NCTTP, BCACP, CDE, considers the benefit of over-the-counter options for battling atopic dermatitis, such as the topical products CeraVe and Eucerin.

A panel of experts discusses diabetes treatment management and the impact pharmacists can have on an increasingly diverse patient population.

Parathyroid hormone (Natpara) is indicated to control hypocalcemia in patients with hypoparathyroidism.

Debra Goff, PharmD, FIDSA, FCCP, infectious diseases specialist at the Ohio State University Wexner Medical Center, discusses Clostridioides difficile awareness and potential future treatments.

Comprehensive discussion on the identification of Clostridioides difficile infection, the spectrum of disease, and overall epidemiology.

A broad review of BTK inhibition as a novel therapeutic approach toward the treatment of marginal zone lymphoma.

The panel reflects on how disruption of the gut microbiome leads to the proliferation of Clostridioides difficile.

Following discussion on the NCCN guidelines for second-line therapy in marginal zone lymphoma, experts highlight approved treatment options.

Ray Tancredi, RPh, MBA, divisional VP of specialty pharmacy development and brand Rx/vaccine purchasing at Walgreens, provides an analysis and overview of key specialty pharmaceuticals in development.